Novo Nordisk A/S (NYSE:NVO)
| 64.41 BATS BZX Real-Time Price As of 12:49pm ET |  -1.01 / -1.54%Today’s Change | 47.72 Today|||52-Week Range 68.96 | +11.28% Year-to-Date |
Latest NVO News | Press Releases
No recent news for Novo Nordisk A/S.
Today’s Trading
| Previous close | 65.42 |
| Today’s open | 64.21 |
| Day’s range | 64.19 - 64.90 |
| Volume | 622,732 |
| Average volume (3 months) | 1,623,512 |
| Market cap | $115.3B |
Data as of 12:49pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | -2.68% |
| Earnings growth (this year) | +13.21% |
| Earnings growth (next 5 years) | +9.36% |
| Revenue growth (last year) | +3.34% |
| P/E ratio | 23.9 |
| Price/Sales | 7.53 |
| Price/Book | 17.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | 0.00 | 0.00% |
| SNYSanofi | -1.38 | -2.59% |
| BMYBristol-Myers Squibb | +0.07 | +0.12% |
| LLYEli Lilly and Co | +1.13 | +0.74% |
Data as of 12:49pm ET, 08/04/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | $0.67 |
| Annual revenue (last year) | $18.3B |
| Annual profit (last year) | $5.8B |
| Net profit margin | 31.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
